Cuprina Holdings (Cayman) LTD Logo

Cuprina Holdings (Cayman) LTD

Biomedical firm specializing in Maggot Debridement Therapy for wound care in Singapore & Hong Kong.

CUPR | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
BLOCK 1090, 169201 SINGAPORE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cuprina Holdings is a biomedical and biotechnology company specializing in the development and commercialization of innovative wound care solutions and cosmeceuticals. The company's primary focus is on Maggot Debridement Therapy (MDT), a biotherapy for chronic wounds like diabetic foot ulcers. Its flagship product, MEDIFLY, uses medical-grade sterile larvae for the non-surgical removal of necrotic tissue, offering a clinically-proven alternative to conventional treatments with demonstrated higher healing rates and faster debridement. The company's portfolio also includes collagen-based wound care products and a range of skin restoration balms and athletic care products. Cuprina primarily serves healthcare providers and patients in Singapore and Hong Kong.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cuprina Holdings (Cayman) LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cuprina Holdings (Cayman) LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cuprina Holdings (Cayman) LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NEOGEN CORP Logo
Provides diagnostic tests and genomics services for food, animal, and agricultural safety.
United States of America NEOG
NEOGENOMICS INC Logo
Provides precision oncology testing for cancer diagnostics, therapy guidance, and research.
United States of America NEO
NeoImmuneTech, Inc. Logo
Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.
United States of America 950220
NEONC TECHNOLOGIES HOLDINGS, INC. Logo
Developing intranasal drug delivery to treat brain cancer & CNS diseases by crossing the BBB.
United States of America NTHI
Neumora Therapeutics, Inc. Logo
Developing data-driven precision medicines for neuropsychiatric and neurodegenerative disorders.
United States of America NMRA
Neuphoria Therapeutics Inc. Logo
Develops novel ion channel modulators for treating neuropsychiatric disorders like anxiety & PTSD.
United States of America NEUP
NEUROCRINE BIOSCIENCES INC Logo
Develops therapies for neurological, neuroendocrine, and neuropsychiatric disorders.
United States of America NBIX
Neurogene Inc. Logo
Developing genetic medicines using gene therapy for rare and devastating neurological diseases.
United States of America NGNE
NeuroSense Therapeutics Ltd. Logo
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
United States of America NRSN
NewAmsterdam Pharma Co N.V. Logo
Developing oral LDL-lowering therapies for high-risk cardiovascular disease patients.
United States of America NAMS

Talk to a Data Expert

Have a question? We'll get back to you promptly.